Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 17, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2025. Go to the latest filing (Q3 2026)

37.7B USDQ4 2025
Total value of stock positions
37.7B USD
Positions
76
Share of the ten largest
34.7%

The ten largest positions Q4 2025

  1. Microsoft 4.1%▲ +32.4%
  2. PNC Financial Services 4.0%▼ −8.4%
  3. Taiwan Semiconductor Manufacturing (ADR) 4.0%▲ +24.6%
  4. Visa Inc. 3.7%▲ +37.5%
  5. Charles Schwab Corporation 3.7%▼ −16.3%
  6. Walt Disney Company (The) 3.4%▲ +7.1%
  7. Air Products 3.1%▲ +30.4%
  8. Mcdonalds Corp 2.9%▲ +7.2%
  9. Bridgebio Pharma Inc 2.9%▼ −9.9%
  10. Fortive 2.8%▼ −6.1%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2025

Positions Q4 2025 per 13F filing, 76 of 76
Symbol Weight Shares Reported value Change Held since
Bridgebio Pharma Inc 2.9% 14,393,934 1.1B USD −9.9% reduced Q2 2019 27 quarters
Adaptive Biotechnologies Cor 1.3% 29,993,708 487.1M USD unchanged Q2 2019 27 quarters
FTV Fortive 2.8% 19,228,265 1.1B USD −6.1% reduced Q3 2019 26 quarters
Api Group Corp 1.2% 11,537,518 441.4M USD −6.2% reduced Q2 2020 23 quarters
Pharvaris N V 0.3% 3,653,310 101.4M USD unchanged Q1 2021 20 quarters
Rallybio Corp < 0.1% 4,194,777 2.9M USD unchanged Q3 2021 18 quarters
Biomarin Pharmaceutical Inc 1.0% 6,036,936 358.8M USD −27.5% reduced Q4 2021 17 quarters
Roivant Sciences Ltd 0.4% 6,443,191 139.8M USD −72.7% reduced Q4 2021 17 quarters
Pepgen Inc < 0.1% 3,482,434 22.7M USD unchanged Q2 2022 15 quarters
Trevi Therapeutics Inc 0.1% 3,198,644 40.0M USD −37.6% reduced Q3 2022 14 quarters
CSX CSX Corporation 1.3% 13,817,539 500.9M USD −13.4% reduced Q4 2022 13 quarters
Newamsterdam Pharma Company 0.4% 4,203,567 147.5M USD −35.1% reduced Q4 2022 13 quarters
TMUS T-Mobile US 2.0% 3,754,218 762.3M USD +15.1% increased Q4 2023 9 quarters
HCA HCA Healthcare 1.2% 999,180 466.5M USD −27.6% reduced Q4 2023 9 quarters
Regal Rexnord Corporation 1.2% 3,223,940 452.4M USD +3.2% increased Q4 2023 9 quarters
CPT Camden Property Trust 1.4% 4,764,495 524.5M USD +23.9% increased Q1 2024 8 quarters
Standard Biotools Inc 0.2% 58,651,170 75.1M USD unchanged Q1 2024 8 quarters
Oric Pharmaceuticals Inc 0.1% 6,572,691 53.8M USD 0.0% reduced Q1 2024 8 quarters
SHW Sherwin-Williams 2.7% 3,172,308 1.0B USD +10.1% increased Q2 2024 7 quarters
JPM JPMorgan Chase 1.6% 1,905,982 614.1M USD −62.3% reduced Q2 2024 7 quarters
CVNA Carvana 1.2% 1,061,533 448.0M USD −49.5% reduced Q2 2024 7 quarters
Inhibrx Biosciences Inc 0.3% 1,437,705 113.6M USD −19.6% reduced Q2 2024 7 quarters
V Visa Inc. 3.7% 3,984,205 1.4B USD +37.5% increased Q3 2024 6 quarters
SCHW Charles Schwab Corporation 3.7% 13,872,905 1.4B USD −16.3% reduced Q3 2024 6 quarters
BAC Bank of America 0.7% 4,494,629 247.2M USD −60.9% reduced Q3 2024 6 quarters
BSX Boston Scientific 0.6% 2,509,808 239.3M USD −5.0% reduced Q3 2024 6 quarters
Ginkgo Bioworks Holdings Inc < 0.1% 3,577,128 29.7M USD unchanged Q3 2024 6 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 4.0% 4,914,896 1.5B USD +24.6% increased Q4 2024 5 quarters
BA Boeing 2.3% 3,953,087 858.3M USD +31.3% increased Q4 2024 5 quarters
ROST Ross Stores 1.5% 3,167,479 570.6M USD +56.5% increased Q4 2024 5 quarters
GM General Motors 1.5% 6,806,095 553.5M USD −47.8% reduced Q4 2024 5 quarters
Mcdonalds Corp 2.9% 3,619,215 1.1B USD +7.2% increased Q1 2025 4 quarters
TSLA Tesla, Inc. 2.0% 1,699,741 764.4M USD +5.6% increased Q1 2025 4 quarters
COF Capital One 1.9% 2,952,317 715.5M USD −60.0% reduced Q1 2025 4 quarters
SE Sea Limited (ADR) 1.2% 3,671,545 468.4M USD +20.8% increased Q1 2025 4 quarters
Tic Solutions Inc 0.9% 34,360,000 347.4M USD unchanged Q1 2025 4 quarters
Amer Sports Inc 0.5% 4,814,290 179.8M USD −24.1% reduced Q1 2025 4 quarters
Sionna Therapeutics Inc 0.3% 3,195,181 131.4M USD unchanged Q1 2025 4 quarters
PNC PNC Financial Services 4.0% 7,287,068 1.5B USD −8.4% reduced Q2 2025 3 quarters
DIS Walt Disney Company (The) 3.4% 11,193,504 1.3B USD +7.1% increased Q2 2025 3 quarters
APD Air Products 3.1% 4,782,534 1.2B USD +30.4% increased Q2 2025 3 quarters
AMD Advanced Micro Devices 2.1% 3,742,191 801.4M USD −10.5% reduced Q2 2025 3 quarters
JCI Johnson Controls 1.9% 5,918,707 708.8M USD −12.9% reduced Q2 2025 3 quarters
UBS Group AG 1.1% 9,128,817 426.0M USD −30.3% reduced Q2 2025 3 quarters
Saia Inc 0.9% 1,088,582 355.4M USD −21.3% reduced Q2 2025 3 quarters
Ralliant Corp 0.4% 3,162,630 161.0M USD −37.8% reduced Q2 2025 3 quarters
CSGP CoStar Group 0.3% 1,442,582 97.0M USD −22.0% reduced Q2 2025 3 quarters
Masimo Corp 0.2% 514,340 66.9M USD −52.1% reduced Q2 2025 3 quarters
MSFT Microsoft 4.1% 3,217,642 1.6B USD +32.4% increased Q3 2025 2 quarters
DKNG DraftKings 1.7% 19,119,912 658.9M USD +27.4% increased Q3 2025 2 quarters
MAA Mid-America Apartment Communities 1.4% 3,880,048 539.0M USD +46.7% increased Q3 2025 2 quarters
Celestica Inc 1.3% 1,699,236 502.3M USD −1.4% reduced Q3 2025 2 quarters
Chewy Inc 1.2% 13,536,645 447.4M USD +146.9% increased Q3 2025 2 quarters
AON Aon plc 0.7% 783,650 276.5M USD −44.6% reduced Q3 2025 2 quarters
Oruka Therapeutics Inc 0.2% 2,666,690 80.8M USD unchanged Q3 2025 2 quarters
GOOGL Alphabet Inc. (Class A) 2.2% 2,666,272 834.5M USD new Q4 2025 1 quarter
ICE Intercontinental Exchange 2.1% 4,803,197 777.9M USD new Q4 2025 1 quarter
AMZN Amazon 1.9% 3,126,816 721.7M USD new Q4 2025 1 quarter
Dicks Sporting Goods Inc 1.4% 2,572,969 509.4M USD new Q4 2025 1 quarter
TMO Thermo Fisher Scientific 1.2% 793,187 459.6M USD new Q4 2025 1 quarter
Stellantis N.v 1.2% 39,062,551 434.3M USD new Q4 2025 1 quarter
CCL Carnival Corporation 1.1% 14,061,827 429.4M USD new Q4 2025 1 quarter
UNH UnitedHealth Group 1.0% 1,197,273 395.2M USD new Q4 2025 1 quarter
CB Chubb Limited 0.8% 1,013,839 316.4M USD new Q4 2025 1 quarter
PGR Progressive Corporation 0.8% 1,331,538 303.2M USD new Q4 2025 1 quarter
LII Lennox International 0.8% 621,311 301.7M USD new Q4 2025 1 quarter
Tradeweb Mkts Inc 0.8% 2,768,659 297.7M USD new Q4 2025 1 quarter
Medline Inc 0.8% 6,959,157 292.3M USD new Q4 2025 1 quarter
Gallagher Arthur J & Co 0.7% 1,040,977 269.4M USD new Q4 2025 1 quarter
DLR Digital Realty 0.6% 1,507,988 233.3M USD new Q4 2025 1 quarter
LOW Lowe's 0.6% 912,040 219.9M USD new Q4 2025 1 quarter
Figma Inc 0.6% 5,752,388 215.0M USD new Q4 2025 1 quarter
Itau Unibanco Hldg S A 0.5% 28,396,545 203.3M USD new Q4 2025 1 quarter
RIOT Riot Platforms 0.4% 12,428,894 157.5M USD new Q4 2025 1 quarter
IQV IQVIA 0.4% 619,236 139.6M USD new Q4 2025 1 quarter
West Pharmaceutical Svsc Inc 0.2% 295,028 81.2M USD new Q4 2025 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Financials 20.1%
  • Technology 10.6%
  • Consumer Discretionary 9.8%
  • Industrials 9.1%
  • Communication Services 7.6%
  • Materials 5.9%
  • Health Care 4.5%
  • Real Estate 3.7%
  • not in our coverage 28.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close